**Core Concept**
The presence of Helicobacter pylori (H. pylori) infection is typically assessed using a combination of clinical evaluation, laboratory tests, and endoscopic examination. The most effective method to detect residual H. pylori infection involves identifying the bacteria's presence or absence in the stomach lining.

**Why the Correct Answer is Right**
The correct answer is **13C-urea breath test**. This non-invasive test detects the presence of H. pylori by measuring the amount of carbon dioxide produced when the bacteria breaks down 13C-urea. The test relies on the fact that H. pylori contains the enzyme urease, which catalyzes the hydrolysis of urea into carbon dioxide and ammonia. By swallowing a 13C-urea-labeled capsule, patients with active H. pylori infection will exhale increased amounts of 13C-labeled carbon dioxide, which can be measured using a breath analyzer. This test is highly sensitive and specific for detecting residual H. pylori infection.

**Why Each Wrong Option is Incorrect**
**Option A:** Serology (blood tests) may indicate past or present infection, but it cannot distinguish between active and resolved infection. Additionally, serology may remain positive for several months after successful treatment.

**Option B:** Endoscopy with biopsy is the gold standard for diagnosing H. pylori infection, but it is more invasive and expensive than the breath test. Moreover, it may not be feasible for repeated testing to monitor treatment response.

**Option C:** Stool antigen testing (SAT) is another non-invasive test that detects H. pylori antigens in stool samples. However, it is less sensitive than the 13C-urea breath test and may produce false-negative results.

**Clinical Pearl / High-Yield Fact**
The 13C-urea breath test is a good option for monitoring treatment response in patients with H. pylori infection, as it can detect residual infection even after successful eradication therapy.

**Correct Answer:** C. Stool antigen testing (SAT)